サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1609645

日本の神経刺激装置市場レポート：刺激タイプ、装置タイプ、用途、エンドユーザー、地域別、2024年～2032年

Japan Neurostimulation Devices Market Report by Stimulation Type, Device Type, Application, End User, and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 122 Pages
納期
5～7営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
日本の神経刺激装置市場レポート：刺激タイプ、装置タイプ、用途、エンドユーザー、地域別、2024年～2032年
出版日: 2024年12月05日
発行: IMARC
ページ情報: 英文 122 Pages
納期: 5～7営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

日本の神経刺激装置市場の市場規模は2023年に7億7,850万米ドルに達しました。今後、IMARC Groupは、市場は2032年までに24億7,230万米ドルに達し、2024年から2032年の間に12.30%の成長率（CAGR）を示すと予測しています。神経疾患の有病率の上昇、高齢化人口の急増、急速な技術進歩、厳格な規制基準、共同研究活動の急増、非薬物療法の受け入れ拡大、有利な償還政策、戦略的な業界提携などが市場成長を促進する主な要因です。

本レポートで扱う主な質問

  • 日本の神経刺激装置市場はこれまでどのように推移し、今後どのように推移するのか？
  • COVID-19が日本の神経刺激装置市場に与えた影響は？
  • 日本の神経刺激装置市場の刺激タイプ別の内訳は？
  • 日本の神経刺激装置市場のデバイスタイプ別の内訳は？
  • 日本の神経刺激装置市場の用途別の内訳は？
  • 日本の神経刺激装置市場のエンドユーザー別の内訳は？
  • 日本の神経刺激装置市場のバリューチェーンにはどのような段階がありますか？
  • 日本の神経刺激装置の主な促進要因と課題は何か？
  • 日本の神経刺激装置市場の構造と主要プレーヤーは？
  • 日本の神経刺激装置市場における競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
  • 市場推定
  • 調査手法

第3章 エグゼクティブサマリー

第4章 日本の神経刺激装置市場-イントロダクション

  • 概要
  • 市場力学
  • 業界動向
  • 競合情報

第5章 日本の神経刺激装置市場情勢

  • 過去および現在の市場動向（2018～2023年）
  • 市場予測（2024～2032年）

第6章 日本の神経刺激装置市場- 刺激タイプ別の内訳

  • 内部刺激
  • 外部刺激

第7章 日本の神経刺激装置市場- 装置タイプ別の内訳

  • SCS（脊髄刺激）装置
  • DBS（脳深部刺激）装置
  • SNS（仙骨神経刺激）装置
  • VNS（迷走神経刺激）装置
  • GES（胃電気刺激）装置
  • 経皮的電気神経刺激装置
  • 経頭蓋磁気刺激装置
  • その他

第8章 日本の神経刺激装置市場- 用途別の内訳

  • 疼痛管理
  • てんかん
  • 本態性振戦
  • 尿失禁および便失禁
  • うつ
  • ジストニア
  • パーキンソン病
  • その他

第9章 日本の神経刺激装置市場- エンドユーザー別の内訳

  • リハビリテーションセンター
  • 病院
  • 医療クリニック
  • その他

第10章 日本の神経刺激装置市場-競合情勢

  • 概要
  • 市場構造
  • 市場プレーヤーのポジショニング
  • 主要成功戦略
  • 競合ダッシュボード
  • 企業評価象限

第11章 主要企業のプロファイル

第12章 日本の神経刺激装置市場- 業界分析

  • 促進要因・抑制要因・機会
  • ポーターのファイブフォース分析
  • バリューチェーン分析

第13章 付録

目次
Product Code: SR112024A21886

Japan neurostimulation devices market size reached US$ 778.5 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 2,472.3 Million by 2032, exhibiting a growth rate (CAGR) of 12.30% during 2024-2032. Rising prevalence of neurological disorders, burgeoning aging population, rapid technological advancements, stringent regulatory standards, surging collaborative research efforts, increasing acceptance of non-pharmacological therapies, favorable reimbursement policies, and strategic industry partnership represent some of the key factors driving the market growth.

Neurostimulation devices are sophisticated medical instruments designed for the precise modulation of the nervous system through controlled electrical impulses. They are strategically placed near specific nerve pathways or brain regions to exert precise stimulation, effectively influencing neural activity. Their applications span diverse medical fields, including pain management, neurological disorders, and mental health conditions. In the realm of pain management, neurostimulation devices have demonstrated effectiveness in alleviating chronic pain by interrupting pain signals. For neurological disorders, such as Parkinson's disease, they offer a means to regulate abnormal brain activity. Additionally, they help in treating mood disorders like depression by targeting mood-regulating circuits. A primary advantage of neurostimulation devices lies in their non-invasive nature, offering a safer alternative to surgical procedures. This minimizes the associated surgical risks and accelerates recovery. Moreover, patients can exercise greater control over their treatment, allowing for adjustments in stimulation parameters, enhancing their overall experience, and contributing to improved outcomes. These devices are available in various types, each tailored to specific medical conditions, such as spinal cord and deep brain stimulators.

Japan Neurostimulation Devices Market Trends:

The Japan neurostimulation devices market is influenced by several key drivers, such as the rising prevalence of neurological disorders, including Parkinson's disease and epilepsy. Additionally, the burgeoning geriatric population in Japan underscores the need for innovative therapeutic solutions, further amplifying market growth. Furthermore, increasing awareness about the benefits of neurostimulation therapies among both healthcare professionals and patients is facilitating the market expansion. In line with this, technological advancements in neurostimulation devices, particularly in terms of precision and minimally invasive techniques, have attracted the attention of medical practitioners, fostering the market growth. Moreover, the collaborative efforts between medical device manufacturers and research institutions in the country have also resulted in the development of cutting-edge neurostimulation technologies, which is stimulating the market growth. Furthermore, the growing inclination towards non-pharmacological therapies, to mitigate the side effects associated with medications, has driven the demand for neurostimulation devices, further boosting the market growth. Apart from this, the increasing acceptance of these devices in the management of chronic pain and mood disorders and the presence of favorable reimbursement policies and robust healthcare infrastructure are fueling market expansion across the country.

Japan Neurostimulation Devices Market Segmentation:

Stimulation Type Insights:

  • Internal Stimulation
  • External Stimulation

Device Type Insights:

  • SCS (Spinal Cord Stimulation) Devices
  • DBS (Deep Brain Stimulation) Devices
  • SNS (Sacral Nerve Stimulation) Devices
  • VNS (Vagus Nerve Stimulation) Devices
  • GES (Gastric Electrical Stimulation) Devices
  • Transcutaneous Electrical Nerve Stimulation Devices
  • Transcranial Magnetic Stimulation Devices
  • Others

Application Insights:

  • Pain Management
  • Epilepsy
  • Essential Tremors
  • Urinary and Fecal Incontinence
  • Depression
  • Dystonia
  • Parkinson's Disease
  • Others

End User Insights:

  • Rehabilitation Centers
  • Hospitals
  • Medical Clinics
  • Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan neurostimulation devices market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan neurostimulation devices market?
  • What is the breakup of the Japan neurostimulation devices market on the basis of stimulation type?
  • What is the breakup of the Japan neurostimulation devices market on the basis of device type?
  • What is the breakup of the Japan neurostimulation devices market on the basis of application?
  • What is the breakup of the Japan neurostimulation devices market on the basis of end user?
  • What are the various stages in the value chain of the Japan neurostimulation devices market?
  • What are the key driving factors and challenges in the Japan neurostimulation devices?
  • What is the structure of the Japan neurostimulation devices market and who are the key players?
  • What is the degree of competition in the Japan neurostimulation devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Neurostimulation Devices Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Neurostimulation Devices Market Landscape

  • 5.1 Historical and Current Market Trends (2018-2023)
  • 5.2 Market Forecast (2024-2032)

6 Japan Neurostimulation Devices Market - Breakup by Stimulation Type

  • 6.1 Internal Stimulation
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2018-2023)
    • 6.1.3 Market Forecast (2024-2032)
  • 6.2 External Stimulation
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2018-2023)
    • 6.2.3 Market Forecast (2024-2032)

7 Japan Neurostimulation Devices Market - Breakup by Device Type

  • 7.1 SCS (Spinal Cord Stimulation) Devices
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2018-2023)
    • 7.1.3 Market Forecast (2024-2032)
  • 7.2 DBS (Deep Brain Stimulation) Devices
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2018-2023)
    • 7.2.3 Market Forecast (2024-2032)
  • 7.3 SNS (Sacral Nerve Stimulation) Devices
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2018-2023)
    • 7.3.3 Market Forecast (2024-2032)
  • 7.4 VNS (Vagus Nerve Stimulation) Devices
    • 7.4.1 Overview
    • 7.4.2 Historical and Current Market Trends (2018-2023)
    • 7.4.3 Market Forecast (2024-2032)
  • 7.5 GES (Gastric Electrical Stimulation) Devices
    • 7.5.1 Overview
    • 7.5.2 Historical and Current Market Trends (2018-2023)
    • 7.5.3 Market Forecast (2024-2032)
  • 7.6 Transcutaneous Electrical Nerve Stimulation Devices
    • 7.6.1 Overview
    • 7.6.2 Historical and Current Market Trends (2018-2023)
    • 7.6.3 Market Forecast (2024-2032)
  • 7.7 Transcranial Magnetic Stimulation Devices
    • 7.7.1 Overview
    • 7.7.2 Historical and Current Market Trends (2018-2023)
    • 7.7.3 Market Forecast (2024-2032)
  • 7.8 Others
    • 7.8.1 Historical and Current Market Trends (2018-2023)
    • 7.8.2 Market Forecast (2024-2032)

8 Japan Neurostimulation Devices Market - Breakup by Application

  • 8.1 Pain Management
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2018-2023)
    • 8.1.3 Market Forecast (2024-2032)
  • 8.2 Epilepsy
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2018-2023)
    • 8.2.3 Market Forecast (2024-2032)
  • 8.3 Essential Tremors
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2018-2023)
    • 8.3.3 Market Forecast (2024-2032)
  • 8.4 Urinary and Fecal Incontinence
    • 8.4.1 Overview
    • 8.4.2 Historical and Current Market Trends (2018-2023)
    • 8.4.3 Market Forecast (2024-2032)
  • 8.5 Depression
    • 8.5.1 Overview
    • 8.5.2 Historical and Current Market Trends (2018-2023)
    • 8.5.3 Market Forecast (2024-2032)
  • 8.6 Dystonia
    • 8.6.1 Overview
    • 8.6.2 Historical and Current Market Trends (2018-2023)
    • 8.6.3 Market Forecast (2024-2032)
  • 8.7 Parkinson's Disease
    • 8.7.1 Overview
    • 8.7.2 Historical and Current Market Trends (2018-2023)
    • 8.7.3 Market Forecast (2024-2032)
  • 8.8 Others
    • 8.8.1 Historical and Current Market Trends (2018-2023)
    • 8.8.2 Market Forecast (2024-2032)

9 Japan Neurostimulation Devices Market - Breakup by End User

  • 9.1 Rehabilitation Centers
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2018-2023)
    • 9.1.3 Market Forecast (2024-2032)
  • 9.2 Hospitals
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2018-2023)
    • 9.2.3 Market Forecast (2024-2032)
  • 9.3 Medical Clinics
    • 9.3.1 Overview
    • 9.3.2 Historical and Current Market Trends (2018-2023)
    • 9.3.3 Market Forecast (2024-2032)
  • 9.4 Others
    • 9.4.1 Historical and Current Market Trends (2018-2023)
    • 9.4.2 Market Forecast (2024-2032)

10 Japan Neurostimulation Devices Market - Competitive Landscape

  • 10.1 Overview
  • 10.2 Market Structure
  • 10.3 Market Player Positioning
  • 10.4 Top Winning Strategies
  • 10.5 Competitive Dashboard
  • 10.6 Company Evaluation Quadrant

11 Profiles of Key Players

  • 11.1 Company A
    • 11.1.1 Business Overview
    • 11.1.2 Product Portfolio
    • 11.1.3 Business Strategies
    • 11.1.4 SWOT Analysis
    • 11.1.5 Major News and Events
  • 11.2 Company B
    • 11.2.1 Business Overview
    • 11.2.2 Product Portfolio
    • 11.2.3 Business Strategies
    • 11.2.4 SWOT Analysis
    • 11.2.5 Major News and Events
  • 11.3 Company C
    • 11.3.1 Business Overview
    • 11.3.2 Product Portfolio
    • 11.3.3 Business Strategies
    • 11.3.4 SWOT Analysis
    • 11.3.5 Major News and Events
  • 11.4 Company D
    • 11.4.1 Business Overview
    • 11.4.2 Product Portfolio
    • 11.4.3 Business Strategies
    • 11.4.4 SWOT Analysis
    • 11.4.5 Major News and Events
  • 11.5 Company E
    • 11.5.1 Business Overview
    • 11.5.2 Product Portfolio
    • 11.5.3 Business Strategies
    • 11.5.4 SWOT Analysis
    • 11.5.5 Major News and Events

12 Japan Neurostimulation Devices Market - Industry Analysis

  • 12.1 Drivers, Restraints, and Opportunities
    • 12.1.1 Overview
    • 12.1.2 Drivers
    • 12.1.3 Restraints
    • 12.1.4 Opportunities
  • 12.2 Porters Five Forces Analysis
    • 12.2.1 Overview
    • 12.2.2 Bargaining Power of Buyers
    • 12.2.3 Bargaining Power of Suppliers
    • 12.2.4 Degree of Competition
    • 12.2.5 Threat of New Entrants
    • 12.2.6 Threat of Substitutes
  • 12.3 Value Chain Analysis

13 Appendix